The 20 Best Drug Induced Dyskinesia Doctors Near Me in Glen Burnie, MD

Stephen Reich is a Neurologist in Baltimore, Maryland. Dr. Reich is rated as an Elite provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Movement Disorders, Parkinson's Disease, Supranuclear Ophthalmoplegia, Deep Brain Stimulation, and Gastrostomy.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Movement Disorders.

Dr. Moukheiber trained in neurology at Tufts Medical Center and completed his fellowship in movement disorders at Johns Hopkins. His primary interests include using telehealth/teleneurology to help bridge the gap between tertiary care available in well-funded facilities and the dearth of it in significantly underserved and remote areas; especially pertaining to movement disorders in general and ataxia in particular. He has worked with a number of non-government organizations and founded his own entity that provides home health care in the form of advanced nursing, physical therapy and occupational therapy to underserved communities in third world countries, with particular emphasis on neurodegenerative diseases. Dr. Moukheiber is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Stiff Person Syndrome, Movement Disorders, Parkinson's Disease, and Drug Induced Dyskinesia.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

As the director of the Johns Hopkins Movement Disorders Division, Dr. Kelly Mills cares for patients who have movement disorders such as Parkinson’s disease, atypical parkinsonism, dystonia, ataxia, tremor and Huntington’s disease. He also evaluates and manages patients needing deep brain stimulation to manage their movement symptoms and provides botulinum toxin treatment for various disorders. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might impact cognitive and psychiatric problems. For instance, Dr. Mills studies how deep brain stimulation, when used to treat movement symptoms, can impact cognitive function such as attention, memory or impulsivity. Dr. Mills is a Maryland native and a graduate of the University of Maryland School of Medicine, where he developed an interest in neurology and movement disorders. He trained at the University of California, San Francisco, where he completed his neurology residency as well as a clinical and research fellowship in movement disorders, with a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia. Dr. Mills is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Movement Disorders, Parkinson's Disease, Essential Tremor, and Drug Induced Dyskinesia.

Oluseyi Fadayomi is a Pain Medicine provider in Glen Burnie, Maryland. Dr. Fadayomi is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Chronic Pain, Cervical Spondylosis, Sacroiliac Joint Disease, and Invertebral Disc Disease.

Charles Simmons is a Pain Medicine provider in Glen Burnie, Maryland. Dr. Simmons is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Chronic Pain, Cervical Spondylosis, Complex Regional Pain Syndrome, and Fibromyalgia.

Jo-hsin Chen is a Neurologist in Glen Burnie, Maryland. Dr. Chen has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. Her top areas of expertise are Migraine, Alcoholic Neuropathy, Migraine with Brainstem Aura, and Cluster Headache.

Dr. Stephen Grill is currently an Assistant Professor at Johns Hopkins University (JHU) in Baltimore and Chair of the Medical Advisory Board of the Parkinson Foundation of the National Capital Area (PFNCA). Dr. Grill received a Ph.D. in Neuroscience and an M.D. from Northwestern University. He then completed a neurology residency at Washington University and a fellowship in movement disorders at the National Institutes of Health. He was the founder of Parkinson’s & Movement Disorders Center of Maryland which is now Neurology Consultants – Parkinson’s & Movement Disorders Center of Maryland, a member of Johns Hopkins Regional Physicians. His research interests include how sensory information is used in the control of movement and how improper use of sensory information may lead to motor impairment. He treats persons with advanced Parkinson’s disease employing advanced technologies, such as Deep Brain Stimulation. Dr. Grill is rated as an Advanced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Restless Legs Syndrome.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Advanced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as an Advanced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

Sangjin Oh is a Neurologist in Glen Burnie, Maryland. Dr. Oh is rated as an Advanced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Migraine, Memory Loss, Epilepsy, and Multiple Sclerosis (MS).

Paul Fishman is a Neurologist in Baltimore, Maryland. Dr. Fishman is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Essential Tremor, Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, and Thalamotomy.

Harvey Singer is a Pediatrics provider in Baltimore, Maryland. Dr. Singer is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Tourette Syndrome, Stereotypic Movement Disorder, Transient Tic Disorder, and Movement Disorders.

Dr. Tom Crawford has been a member of the Department of Neurology since 1987. He is co-director of the MDA clinic for Neuromuscular Disorders and Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins. His practice involves general child neurology with a principal interest in caring for children with neuromuscular, neuromotor, and ataxic disorders. Primary research interests involve the basic science and clinical characterization of two important neurologic disorders that affect children: Spinal Muscular Atrophy and Ataxia Telangiectasia. He is also actively involved in the Biology of neurofilaments by characterization of transgenic animal models. He is on the Medical and Scientific Advisory Boards of Families of Spinal Muscular Atrophy, and the Medical Advisory Committee for the Muscular Dystrophy Association. He is the Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins, which has evaluated almost half of the known patients with this disorder in the United States. Additional specific clinical interests include evaluation and treatment of children with brachial plexus palsies. Dr. Crawford received his medical degree from the University of Southern California. He completed a pediatric internship and residency at the Pediatric Pavilion of the Los Angeles County / University of Southern California Medical Center, followed by a pediatric chief residency. He completed his training in Neurology with Special Qualification in Child Neurology at the Los Angeles Childrens Hospital. He then traveled east to the laboratory of Dr John Griffin at Johns Hopkins for a fellowship in Neuromuscular Disorders. Prior to medical training and Neurology residency, he majored in Psychology and Religion at Yale College. Dr. Crawford has published extensively and presented nationally and internationally. He has an active role in teaching medical students and residents in neurology. In addition, Dr. Crawford has special interest and experience in EMG studies of children and adults. Dr. Crawford is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Ataxia-Telangiectasia, and Spinal Muscular Atrophy Type 2.

Neurologist Ashley Paul specializes in movement disorders and also serves as a clinician educator. Dr. Paul has expertise in Parkinson's Disease, atypical parkinsonism, tremors, chorea, dystonia, ataxia, restless leg syndrome, rapid eye movement sleep behavioral disorders, periodic limb movement of sleep and deep brain stimulation. She offers botulinum toxin injections for the treatment of dystonia. Dr. Paul is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. Her top areas of expertise are Movement Disorders, Hereditary Ataxia, Parkinson's Disease, and Drug Induced Dyskinesia.

Dr. Barañano earned her M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine, where she also completed residencies in pediatrics and neurology, along with a fellowship in neurogenetics at the Kennedy Krieger Institute. Dr. Barañano is an Associate Professor of Clinical Neurology. She specializes in the diagnosis and management of rare neurogenetic disorders. She has a particular interest in the genetic control and function of the cerebellum and expertise in childhood-onset and inherited ataxias. She is a member of the multidisciplinary Fetal Management group and is available for prenatal consultations. Dr. Barañano's research includes collaborative efforts with the Johns Hopkins Department of Genetic Medicine and the Division of Neurogenetics at the Kennedy Krieger Institute. Dr. Baranano is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. Her top areas of expertise are Hypotonia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Focal or Multifocal Malformations in Neuronal Migration, and Spinocerebellar Ataxia Type 3.

Dr. R. Samuel Mayer is an associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His clinical interests include complications of critical illness, spine disorders, pain management, disorders of muscle tone and cancer rehabilitation. Dr. Mayer serves as the director of cancer rehabilitation, director of undergraduate medical education and residency program director for the Department of Physical Medicine and Rehabilitation. He graduated from the honors program in medical education at Northwestern University School of Medicine and completed his residency in physical medicine and rehabilitation at Rush Medical College. He was chair of the Committee on Medical Education for the American Medical Student Association while he was a medical student. After completing his residency, he remained on faculty at Rush Medical College, eventually becoming the residency program director and acting chair of the Department of Physical Medicine and Rehabilitation. He joined the Department of Physical Medicine and Rehabilitation at Johns Hopkins in 2001. Dr. Mayer serves as director of the Medical Student Summer Clinical Experience in Physical Medicine and Rehabilitation for the Association of Academic Physiatrists. He is Editor in Chief of Knowledge NOW, the American Academy of Physical Medicine and Rehabilitation's online encyclopedia of the field. In 2014, he was named Distinguished Clinician by the American Academy of Physical Medicine and Rehabilitation. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Pediatric Low-Grade Glioma (pLGG), Hemiplegia, Miller-Fisher Syndrome, and Guillain-Barre Syndrome.

Dr. Ricardo Roda earned a combined MD/PhD degree from University of Rochester and completed an adult neurology residency, followed by a clinical neuromuscular fellowship at Johns Hopkins University School of Medicine. During residency, Dr. Roda developed a special interest in both auto-immune disorders and genetic disorders. Following residency, he spent three years in neurogenetics branch of National Institute of Neurological Disorders and Stroke (NINDS) working with Dr. Craig Blackstone, focusing on the use of the newer DNA sequencing techniques in genetic diagnosis, and in establishing genotype/phenotype correlations neuromuscular disorders. His current clinical interests include developing testing strategies for undiagnosed genetic disorders and myasthenia gravis. Dr. Roda is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Spastic Paraplegia Type 7, Hereditary Spastic Paraparesis, Myasthenia Gravis, and Spastic Paraplegia Type 2.

Dr. William Anderson provides comprehensive treatments - such as including deep brain stimulation (DBS) therapies -for movement disorders including, Parkinson's disease, essential tremor, and dystonia. Dr. William Anderson is also a member of the Epilepsy Surgery team, and performs both resectional procedures such as temporal lobectomy, diagnostic procedures such as implantation of monitoring grids and depth electrodes, and therapeutic neuromodulation using vagal nerve and cortical stimulation. Procedures for pain and spasticity performed include intrathecal baclofen therapy and spinal cord stimulation therapy. Dr. Anderson is rated as an Experienced provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Parkinson's Disease, Essential Tremor, Spasticity, Deep Brain Stimulation, and Awake Craniotomy.